Heron Therapeutics Publishes Clinical Trial Titled ‘HTX-011 in Spinal Surgery’ To ClinicalTrials.Gov
https://clinicaltrials.gov/ct2/show/NCT04911062
Bristol Myers’ Opdivo-Yervoy Combo Approved In Europe, Canada For Malignant Pleural Mesothelioma
The regulatory authorities in Europe and Canada have approved Bristol Myers Squibb & Co’s (NYSE:BMY) Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment…
Mereo’s Alvelestat Shows Encouraging Biomarker Data In Bronchiolitis Obliterans Syndrome
Mereo BioPharma Group plc (NASDAQ:MREO) has announced data from an interim analysis of an investigator-initiated study of alvelestat, in patients with…
Lixte Biotechnology, City Of Hope Enroll First Patient In Phase 1b Trial Of Lead Compound LB-100 For Treatment Of Small Cell Lung Cancer
Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer
Extensive preclinical data shows LB-100 increases the effectiveness
Seres Therapeutics Gets FDA Green Signal to Start SER-155 Human Trials
The FDA has signed off Seres Therapeutics Inc’s (NASDAQ:MCRB) Investigational New Drug (IND) application for SER-155 to initiate Phase 1 trial.…
BeyondSpring’s Plinabulin US Application for Chemo-Induced Neutropenia Under Review
The FDA has accepted for review BeyondSpring Inc’s (NASDAQ:BYSI) marketing application seeking approval for the use of plinabulin in combination with…
Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related Anemia
Akebia Therapeutics Inc (NASDAQ:AKBA) and its collaborator Otsuka Holdings (OTC:OTSKY) have announced that the FDA has accepted to review vadadustat’s marketing application for…
Sanofi Stops Venglustat Development In Rare Genetic Kidney Disorder
Sanofi SA (NASDAQ:SNY) has halted the clinical program of venglustat in autosomal dominant polycystic kidney disease (ADPKD). Although the safety profile…